On the growth rates of human malignant tumors: Implications for medical decision making

@article{Friberg1997OnTG,
  title={On the growth rates of human malignant tumors: Implications for medical decision making},
  author={Sten Friberg and Stefan Mattson},
  journal={Journal of Surgical Oncology},
  year={1997},
  volume={65}
}
Testicular carcinomas, pediatric tumors, and some mesenchymal tumors are examples of rapidly proliferating cell populations, for which the tumor volume doubling time (TVDT) can be counted in days. Cancers from the breast, prostate, and colon are frequently slow‐growing, displaying a TVDT of months or years. Irrespective of their growth rates, most human tumors have been found: to start from one single cell, to have a long subclinical period, to grow at constant rates for long periods of time… 

Cancer Metastases : Early Dissemination and Late

Dormancy might be reversible and lead to late recurrences in human malignant tumors, and CMM, RCC, and malignant glioblastoma were the three most common malignancies resulting from an organ transplantation.

Cancer Metastases: Early Dissemination and Late Recurrences

Dormancy might be reversible and lead to late recurrences in human malignant tumors, and CMM, RCC, and malignant glioblastoma were the three most common malignancies resulting from an organ transplantation.

Cancer Metastases: Early Dissemination and Late Recurrences

Dormancy might be reversible and lead to late recurrences in human malignant tumors, and CMM, RCC, and malignant glioblastoma were the three most common malignancies resulting from an organ transplantation.

Progression rates of colorectal cancer in high-risk individuals.

Based on the calculated progression rates, the authors to clinical disease may have been affected by detection concluded that colorectal cancer is likelier to progress bias.

The challenge of early detection in cancer

Further research is needed to improve cancer early detection methods, but fundamental issues surrounding tumor growth dynamics and the timing of metastasis make early detection challenging.

Role of myeloid-derived suppressor cells in metastasis

It is posited herein that the immunosuppressive mechanisms mediated by myeloid-derived suppressor cells (MDSCs) are a major contributor to tumor progression, and that these mechanisms promote tumor cell escape from dormancy.

Chronology of metastasis in cutaneous melanoma: growth rate model.

A correlation exists between the critical time of onset of metastatic potential and the GR of the melanoma, and the fastest-growing melanomas began metastasizing with a greater thickness than the slowest- growing melanomas.

Myeloid derived suppressor cells and the release of micro-metastases from dormancy

MDSC expansion, driven by tumor burden associated growth factor secretion and their role in tumor cell escape from dormancy, resulting in manifest metastases is discussed and the therapeutic strategies to inhibit MDSCs expansion and function are discussed.

Modeling progression in radiation-induced lung adenocarcinomas

It is shown, using cohort simulations with parameters appropriate for lung adenocarcinomas, that incorporating such processes can dramatically lengthen predicted latency periods, suggesting that radiation may influence progression itself.
...

References

SHOWING 1-10 OF 210 REFERENCES

Breast cancfr–‐influence of growth rate on prognosis and treatment evaluation. A study based on mastectomy scar recurrences

The appreciable number of patients with tumors exhibiting slow or intermediate growth rates, in any series, suggests that the use of the 5‐year interval is an inadequate measure of therapeutic response in breast cancer and may actually be misleading.

[Growth rate and natural history of breast cancer].

Analysis of the data indicate that half of the metastases began to grow more than about two years before the time when the primary tumor reached a clinically detectable size.

OBSERVATIONS ON THE GROWTH RATE OF RENAL CELL CARCINOMA

The results suggest that, in addition to the proliferative activity of cancer cells, the microenvironment of the specific region is an important determinant of the growth rate ofcancer cells.

Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review.

A strategy based on cell kinetics principles and tumor doubling time data is proposed for improving therapeutic results in responsive tumors and may also apply in adjuvant therapy of slowly growing tumors.

Growth rates of small cell bronchogenic carcinomas

The data indicate that small cell bronchogenic carcinoma of the lung is a relatively slowly growing tumor, and residual body tumor burdens of 1 × 106 cells may be followed by tumor recurrence times of 2 years or longer; the likelihood of "cure" should not be entertained in patients with disease‐free intervals shorter than 4—5 years.

Tumor Growth Rate and Prognosis of Breast Cancer Mainly Detected by Mass Screening

The Cox multiple regression analysis showed that the tumor growth rate was related significantly with survival, after adjusting for other covariates such as clinical stage, lymph node metastasis, age of patient, histological type, and year of treatment.

Tumor growth, doubling times, and the inability of the radiologist to diagnose certain cancers.

Tumor growth, doubling times, and the inability of the radiologist to diagnose certain cancers.

Data support the presence of a subset of acute breast cancers below threshold size at examination but that can grow to clinically detectable and symptomatic size within weeks to months of the breast evaluation showing no abnormality.

Rates of growth of human solid neoplasms: Part I

It is concluded that a more accurate quantification of the growth rates of human cancer is essential for understanding the biological variance of human cancers seen clinically.

Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications.

...